Study to assess the prevalence of chronic kidney disease in Type 2 Diabetes.
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Type 2 Diabetes
- Registration Number
- CTRI/2015/05/005769
- Lead Sponsor
- AstraZeneca Pharma India Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 3000
Inclusion Criteria
•Known cases of T2DM.
•Male and female patients aged 18 years and above
•Must provide written Informed consent.
Exclusion Criteria
•Patients with known type-1 diabetes.
•Patients with any form of acute kidney injury based on investigatorâ??s discretion.
•Patients on maintenance dialysis or known renal transplant patients.
•Patients with symptomatic Urinary Tract Infection (UTI) or with history of hematuria.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method